Beijing Aosaikang Pharmaceutical Co., Ltd.

XSEC:002755 Stock Report

Market Cap: CN¥12.3b

Beijing Aosaikang Pharmaceutical Future Growth

Future criteria checks 2/6

Beijing Aosaikang Pharmaceutical is forecast to grow earnings and revenue by 21.7% and 13.6% per annum respectively. EPS is expected to grow by 22.9% per annum. Return on equity is forecast to be 4.7% in 3 years.

Key information

21.7%

Earnings growth rate

22.9%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth rate13.6%
Future return on equity4.7%
Analyst coverage

Low

Last updated23 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:002755 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,31517470901
12/31/20251,99974-3621
12/31/20241,77332-173-691
9/30/20241,708163277430N/A
6/30/20241,65486205366N/A
3/31/20241,553-48122283N/A
12/31/20231,443-149-156-27N/A
9/30/20231,486-342-251-102N/A
6/30/20231,574-397-258-114N/A
3/31/20231,676-314-331-183N/A
1/1/20231,873-226-203-53N/A
9/30/20222,169-80201327N/A
6/30/20222,443129179281N/A
3/31/20222,711221430534N/A
1/1/20223,107380434568N/A
9/30/20213,513634328437N/A
6/30/20213,954757458599N/A
3/31/20214,005793352462N/A
12/31/20203,783722381580N/A
9/30/20203,697674266504N/A
6/30/20203,720627222490N/A
3/31/20204,114699376669N/A
12/31/20194,519781366535N/A
9/30/20194,507773346493N/A
6/30/20194,279729411506N/A
3/31/20194,068699285363N/A
12/31/20183,932670401497N/A
12/31/20173,405608N/A686N/A
12/31/20163,092630N/A786N/A
12/31/20153,011509N/A689N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002755's forecast earnings growth (21.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 002755's earnings (21.7% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 002755's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002755's revenue (13.6% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 002755's revenue (13.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002755's Return on Equity is forecast to be low in 3 years time (4.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y